[go: up one dir, main page]

AU2001286562A1 - Use of agaricus blazei murill to prevent or treat skin and other disorders - Google Patents

Use of agaricus blazei murill to prevent or treat skin and other disorders

Info

Publication number
AU2001286562A1
AU2001286562A1 AU2001286562A AU8656201A AU2001286562A1 AU 2001286562 A1 AU2001286562 A1 AU 2001286562A1 AU 2001286562 A AU2001286562 A AU 2001286562A AU 8656201 A AU8656201 A AU 8656201A AU 2001286562 A1 AU2001286562 A1 AU 2001286562A1
Authority
AU
Australia
Prior art keywords
disorders
prevent
treat skin
agaricus blazei
blazei murill
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286562A
Inventor
Kenji Haramaki
Shoji Uchiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ATLAS WORLD USA Inc
Original Assignee
ATLAS WORLD USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ATLAS WORLD USA Inc filed Critical ATLAS WORLD USA Inc
Publication of AU2001286562A1 publication Critical patent/AU2001286562A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/071—Agaricus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
AU2001286562A 2000-08-18 2001-08-20 Use of agaricus blazei murill to prevent or treat skin and other disorders Abandoned AU2001286562A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22647500P 2000-08-18 2000-08-18
US60226475 2000-08-18
PCT/US2001/025996 WO2002015917A1 (en) 2000-08-18 2001-08-20 Use of agaricus blazei murill to prevent or treat skin and other disorders

Publications (1)

Publication Number Publication Date
AU2001286562A1 true AU2001286562A1 (en) 2002-03-04

Family

ID=22849043

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286562A Abandoned AU2001286562A1 (en) 2000-08-18 2001-08-20 Use of agaricus blazei murill to prevent or treat skin and other disorders

Country Status (5)

Country Link
US (2) US20020119164A1 (en)
EP (1) EP1409000A4 (en)
JP (1) JP2004506689A (en)
AU (1) AU2001286562A1 (en)
WO (1) WO2002015917A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002087603A1 (en) * 2001-04-27 2002-11-07 Ajinomoto Co., Inc. Immunopotentiators
EP1535621A4 (en) * 2002-07-02 2006-08-30 Kyowa Eng EXTRACT OF AGARICUS BLAZEI MURILL FOR THE PREVENTION OF THE APPEARANCE OF CANCER OR METASTASIS
US7807622B2 (en) * 2004-04-23 2010-10-05 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
US20050238654A1 (en) * 2004-04-26 2005-10-27 Yoshinori Takeda Compositions and methods for weight loss
JP5034071B2 (en) * 2004-09-17 2012-09-26 株式会社Ｓ・Ｓ・Ｉ Kawariharatake extract that suppresses breast cancer
US8586053B2 (en) * 2005-09-21 2013-11-19 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
BR112012011678A2 (en) * 2009-11-16 2018-04-17 Health Enhancement Products Inc composition and methods to affect cytokine and nf-kb production
CA2827401A1 (en) 2010-02-22 2011-08-25 Health Enhancement Products, Inc. Agents and mechanisms for treating hypercholesterolemia
BRPI1002067A8 (en) * 2010-05-11 2017-10-31 Coop Dos Produtores De Cogumelos Da Regiao Metropolitana De Belohorizonte – Minasfungi Do Brasil LEISHMANICIDAL FORMULATION AND ITS USE
US10232028B2 (en) 2013-06-13 2019-03-19 Zivo Bioscience, Inc. Compounds and methods for affecting cytokines
CN104547417A (en) * 2014-12-26 2015-04-29 王希龙 Medicine for treating goiter
US10092609B2 (en) 2015-01-16 2018-10-09 James A. Wieser Process for preparing medicinal mycological preparations
BR112017017599B1 (en) 2015-02-16 2021-11-16 Zivo Bioscience, Inc. USES OF AN ALGAL BIOMASS OR OF A SUPERNATANT DERIVED FROM AT LEAST ONE KLEBSORMIDIUM ALGAE SPECIES
CN105056137A (en) * 2015-08-24 2015-11-18 济南邦文医药科技有限公司 Traditional Chinese medicine composition for treating toxic and diffuse goiter
CN105056033A (en) * 2015-08-24 2015-11-18 济南邦文医药科技有限公司 Traditional Chinese medicine for treating incision effusion and relieving pains after endoscopic thyroid operation
CA3014897C (en) 2016-02-16 2020-12-29 Zivo Bioscience, Inc. Nutritional support for animals via administration of an algal derived supplement
DK3503738T3 (en) * 2016-08-26 2021-06-07 Nutreco Ip Assets Bv Animal feed supplements and animal feed containing it
CN110467978B (en) * 2019-09-11 2021-04-13 福建师范大学泉港石化研究院 Whitening antibacterial miraculin soap and preparation method thereof
IL300067A (en) * 2020-07-21 2023-03-01 Ai Pharmaceuticals Jamaica Ltd Compositions and methods for treatment of cancers
EP4331598A1 (en) 2022-08-29 2024-03-06 Mycotech Pharma AS Antiviral fungal extracts
WO2024046653A1 (en) 2022-08-29 2024-03-07 Mycotech Pharma As Antiviral fungal extracts
CN118649222B (en) * 2024-08-19 2024-12-27 吉林省芫宁生物科技有限公司 Polypeptide composite Pickering emulsion for efficiently supplementing protein, preparation method and application

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5048227A (en) * 1988-05-05 1991-09-17 Junya Okubo Method of cultivating agaricus blazei mushroom
JP3051073B2 (en) * 1996-12-20 2000-06-12 住友林業株式会社 Antitumor active substance
US6378244B1 (en) * 1997-02-12 2002-04-30 Imb Kabushiki Gaisha Method of cultivating fruit bodies of agaricus blazei in artificial mushroom cultivation bed
US6465218B1 (en) * 1997-04-08 2002-10-15 Japan Applied Microbiology Research Institute Co., Ltd. Biologically active substance and process of preparing the same
US5980918A (en) * 1997-10-24 1999-11-09 Brennen Medical, Inc. β-D-glucan topical composition
JP3630388B2 (en) * 1997-10-28 2005-03-16 株式会社ノエビア Topical skin preparation
US6036946A (en) * 1997-12-24 2000-03-14 Shaklee Corporation Methods for protecting skin from damaging effects of ultraviolet light
US6120772A (en) * 1998-10-08 2000-09-19 Hitoshi Ito Oral drugs for treating AIDS patients
US20020110564A1 (en) * 1999-12-10 2002-08-15 Mark Itokawa Nutriceutical composition and methods

Also Published As

Publication number Publication date
EP1409000A1 (en) 2004-04-21
JP2004506689A (en) 2004-03-04
WO2002015917A1 (en) 2002-02-28
EP1409000A4 (en) 2004-04-21
US20050008655A1 (en) 2005-01-13
US20020119164A1 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
AU2001286562A1 (en) Use of agaricus blazei murill to prevent or treat skin and other disorders
ZA200505272B (en) Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
GB0025639D0 (en) Cosmetic treatment of skin conditions
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2003265225A1 (en) Preparations for topical skin use and treatment
AU2001280440A1 (en) Treatment of human herpesviruses using hyperthermia
IL127943A (en) Pharmaceutical and cosmetic compositions for the treatment of skin disorders
AUPQ877300A0 (en) Topical treatment of skin
AU7067200A (en) Skin care compositions and treatments
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU1492401A (en) Cleanser that is gentle to human skin
AU2002952597A0 (en) Topical parasiticide formulations and methods of treatment
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU7106300A (en) Treatment of skin disorders
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2001276462A1 (en) Use of natural products in cancer treatment
HK1067304A (en) Use of agaricus blazei murill to prevent or treat skin and other disorders
AU2001284380A1 (en) Therapeutic and cosmetic uses of heparanases
AU2002211561A1 (en) Regulation of human skin healing
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2002214950A1 (en) Determination of the ability of patients to respond to tumour treatment
AU2001284743A1 (en) Therapeutic topical solution for skin and associated methods of use